787-放射协同诱导型AAV平台编程抗肿瘤免疫 episode artwork

EPISODE · Apr 13, 2026 · 20 MIN

787-放射协同诱导型AAV平台编程抗肿瘤免疫

from 聊聊Sci

这项研究揭示了放射治疗(RT)与腺相关病毒(AAV)免疫疗法之间的协同机制,为癌症治疗提供了新策略。研究发现,放电能通过表观遗传重塑显著增强肿瘤对AAV向量的转导效率。科学家据此设计了一种干扰素诱导型AAV平台,实现了细胞因子IL-12在辐照肿瘤区域的精准空间控制。这种组合疗法能重塑肿瘤微环境,有效诱导局部及全身性的抗肿瘤免疫反应。实验证明,该方法在多种模型中均能抑制肿瘤生长,且避免了传统细胞因子疗法常见的全身毒性。最终,这种治疗方案利用IFNγ依赖和FAS介导的机制,成功克服了肿瘤的免疫逃逸。References: Marco S, Fernández M, Honorato B, et al. Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity[J]. Cancer Cell, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Apr 13, 2026

Embed this episode

Ready to play

787-放射协同诱导型AAV平台编程抗肿瘤免疫

0:00 20:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 20 minutes long.

When was this 聊聊Sci episode published?

This episode was published on April 13, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!